Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Deals

Daily deal net: May 7, 2021
7th May 2021
Thierry Heles
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Dyno Therapeutics evolves to raise $100m
7th May 2021
Robert Lavine
Advancing Harvard Medical School research, Dyno Therapeutics has raised $100m to advance its gene therapies based on AAV.
TwinStrand takes in $50m
7th May 2021
Thierry Heles
UW spinout TwinStrand has completed a $50m series B round led by Section 32, while Alexandria Venture Investments invested a third time.
Mainspring Energy bounces to $95m series D
6th May 2021
Jordan Williams
American Electric Power, Chevron and Equinor all participated in a round that increased the Stanford company’s total funding to $228m.
Affinia achieves $110m series B close
5th May 2021
Robert Lavine
GV, Mass General Brigham Ventures and Lonza helped Affinia Therapeutics raise $110m to commercialise work originating at Harvard.
Solid Power recharges with $130m
5th May 2021
Robert Lavine
CU Boulder’s solid-state battery provider pulled in funding through a series B round co-led by potential customers BMW and Ford.
Daily deal net: May 5, 2021
5th May 2021
Thierry Heles
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Werewolf Therapeutics hunts $120m in IPO
5th May 2021
Jordan Williams
The UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

News Continued

Mogrify magnifies series A
5th May 2021
Thierry Heles
Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.
Zoe dishes up $20m series B
5th May 2021
Thierry Heles
Ahren Innovation Capital has helped bring Zoe’s overall financing to $53m by leading a series B round for the personalised nutrition service.
Bibit.id brings in $65m
5th May 2021
Thierry Heles
Harvard University’s endowment has participated in a funding round for the robo-advisory platform.
Kuur inks $185m acquisition
5th May 2021
Thierry Heles
Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.
Inivata inspires $390m acquisition
5th May 2021
Thierry Heles
NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.
Oxford Nanopore orchestrates $270m round
4th May 2021
Thierry Heles

Editor's Picks

Big deal: Oxford PV begins capturing series D
18th March 2019
Thierry Heles
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
7th January 2019
Thierry Heles
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
17th December 2018
Callum Cyrus
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
5th November 2018
Thierry Heles
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
© 2021 Mawsonia Ltd. All rights reserved.
test reg

Login

Forgot password?

Not yet subscribed?

See your subscription offers here